HemOnc Today Current Issue
The following articles appeared in the print edition of HemOnc Today.
Table of Contents
- Pediatric cancer pain management requires balancing function with comfort Jennifer Byrne
-
- FDA grants orphan drug designation to CSL889 for sickle cell disease
- Should opioids continue to be a component of pain management for children with cancer?
- 6 years at the helm: A Decameron Derek Raghavan, MD, PhD, FACP, FRACP, FASCO; John Sweetenham, MD, FRCP, FACP
- Looking back, not forward Nicholas J. Petrelli, MD, FACS
- Accurately attributing toxicity with combination regimens: An emerging practice challenge Kimberly D. Allman, MSN, CNP, AOCNP
- Education, communication can reduce risks of cannabidiol use among patients with cancer Jill S. Bates, PharmD, MS, BCOP, FASHP
- Web-based app can help weigh impact of cancer treatment delays during COVID-19 pandemic John DeRosier
- Longitudinal study reveals mechanism of early puberty as a driver of breast cancer risk Jennifer Byrne
-
- Blood test identifies pancreatic cancers that respond to adjuvant chemotherapy Jennifer Byrne
- Research links rare, pathogenic variants with COVID-19 severity Jennifer R. Southall
- Pregnancy after breast cancer ‘should not be discouraged’ Mark Leiser
- Circulating tumor cells may predict OS in metastatic breast cancer Mark Leiser
- 5-year data show sustained benefit of venetoclax-rituximab for relapsed/refractory CLL Alexandra (Sasha) Todak
- Fauci: COVID-19 can be crushed, ‘but it’s not going to happen in a few months’ Alexandra (Sasha) Todak
- Single-dose gene therapy ‘pretty transformative’ for patients with hemophilia B Drew Amorosi
- Atezolizumab plus bevacizumab improves survival outcomes vs. sorafenib in unresectable HCC John DeRosier
-
- Noninvasive assay outperforms standard cytology in detection of urothelial carcinoma Jennifer R. Southall
- Cytoreductive nephrectomy may benefit certain patients with renal cell carcinoma Jennifer R. Southall
- Diagnostic radiation below the waist may increase risk for testicular cancer John DeRosier
- Transoral robotic surgery linked to survival benefit in early-stage oropharyngeal cancer John DeRosier
- Prognostic model identifies patients with CLL at risk for ibrutinib failure Alexandra (Sasha) Todak
- Older patients with melanoma may have poorer response to anti-VEGF therapy John DeRosier
- Continuous nivolumab appears effective, safe in advanced NSCLC Jennifer R. Southall
- Complete excision improves survival after induction therapy for high-risk neuroblastoma Jennifer R. Southall
-
- FDA grants breakthrough therapy designation to MK-6482 for renal cell carcinoma subtype
- FDA grants orphan drug designation to APX005M for three cancer types
- FDA grants fast track designation to rilzabrutinib for immune thrombocytopenia
- FDA approves Keytruda for triple-negative breast cancer subset
- FDA grants priority review to Enhertu for gastric cancer subset
- FDA grants priority review to Xalkori for certain children with lymphoma
- FDA grants orphan drug designation to novel glioblastoma treatment
- FDA approves FoundationOne CDx test as companion diagnostic for Vitrakvi
-
- FDA grants orphan drug designation to KN046 for thymic epithelial tumors
- ASH announces four new executive committee members
- UCLA names inaugural chair in integrative oncology
- Roswell Park Comprehensive Cancer Center appoints nursing executives
- AABB installs 2020-2021 president
- Inaugural class of FDA-AACR oncology educational fellows announced